| 30-May-2013 | D | Aanjaneya Lifecare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has :
1. Recommended a Dividend, subject to the approval of shareholders in the ensuing Annual General Meeting of the Company @ 1.00 % on 1,38,87,151 Equity Shares of the Rs. 10/- each (i.e. Rs. 0.10/- (Ten Paise) per Equity Share) to the concerned shareholders as on Record Date. | 20-Sep-2013 | |
| 30-May-2012 | D | Aanjaneya Lifecare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has recommended a Dividend, subject to the approval of shareholders in the ensuing Annual General Meeting of the Company @ 20% on 1,38,87,151 Equity Shares of the Rs. 10/- each (i.e. Rs. 2/- per Equity Share). | 31-Aug-2012 | |
| 04-Mar-2021 | BC | (As Per NSE Circular Dated on 04.03.2021) | 05-Mar-2021 | |
| 12-Feb-2020 | BC | Trading Members of the Exchange are hereby informed that the undermentioned 28 suspended companies at the Exchange have been delisted by NSE. In view thereof in terms of Rule 21(2)(b) of the Securiti | 14-Feb-2020 | |
| 15-Jun-2018 | BC | Sub : Delisting
In terms of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 ('Regulations'), Section 21A of the Securities Contract (Regulations) Act, 1956 | 02-Jul-2018 | |
| 12-Jun-2015 | BC | Dr.Datsons Labs Ltd has informed BSE that the following changes in Directorship of the Company have taken place:
1. The Change in designation of Mr. Rajendra Kamat, as a Non Executive Director o | 25-May-2015 | |
| 18-May-2015 | BC | Sub:- Suspension of Trading in the Equity Shares of Dr.Datsons Labs Ltd and S. Kumars Nationwide Limited.
Trading members are hereby informed that the following companies are under Liquidation f | 22-May-2015 | |
Announcement Date30-May-2013
Ex Dividend Date20-Sep-2013
Dividend(%)1
Announcement Date30-May-2012
Ex Dividend Date31-Aug-2012
Dividend(%)20
No Bonus has been declared by Dr-Datsons-Labs-Ltd
No Split has been declared by Dr-Datsons-Labs-Ltd
RightsNo Rights has been declared by Dr-Datsons-Labs-Ltd
Book Closure
| 05-Mar-2021 | - | (As Per NSE Circular Dated on 04.03.2021) |
| 14-Feb-2020 | - | Trading Members of the Exchange are hereby informed that the undermentioned 28 suspended companies at the Exchange have been delisted by NSE. In view thereof in terms of Rule 21(2)(b) of the Securiti |
| 02-Jul-2018 | - | Sub : Delisting
In terms of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 ('Regulations'), Section 21A of the Securities Contract (Regulations) Act, 1956 |
| 25-May-2015 | - | Dr.Datsons Labs Ltd has informed BSE that the following changes in Directorship of the Company have taken place:
1. The Change in designation of Mr. Rajendra Kamat, as a Non Executive Director o |
| 22-May-2015 | - | Sub:- Suspension of Trading in the Equity Shares of Dr.Datsons Labs Ltd and S. Kumars Nationwide Limited.
Trading members are hereby informed that the following companies are under Liquidation f |